The biology of female fertility after 35 does not decline uniformly or predictably. Two women of the same age can have dramatically different ovarian reserves, hormonal profiles, and underlying conditions that determine their fertility prognosis and their response to treatment. What changes after 35 is not simply that pregnancy becomes harder it is that the margin for error in treatment narrows, the diagnostic workup needs to be more thorough, and the specialist managing the case needs to understand the specific interplay between age, ovarian reserve, existing conditions like PCOS or endometriosis, and the ART protocol selected. Dr. Anindita Singh at Nova IVF Fertility Centre, Kolkata is one of the most experienced female infertility specialists managing this patient group in Eastern India. With 24 years of practice and over 2,000 IVF cycles, she is specifically known for handling difficult IVF cases and prioritising self-cycle IVF using the patient's own eggs wherever this remains biologically viable.
This guide draws on her clinical expertise and the evidence base for female infertility treatment in India for women navigating the challenges of fertility after 35.
What Changes After 35: The Biology Women Need to Understand
Women over 35 seeking female infertility treatment face a specific biological reality that shapes every aspect of diagnosis and treatment selection. Understanding it removes the fog of vague reassurance and allows women to make genuinely informed decisions.
Declining Ovarian Reserve
Anti-Mullerian hormone (AMH) is the most reliable marker of ovarian reserve — the functional pool of eggs remaining in the ovaries. AMH declines with age, but the rate of decline varies considerably between individuals. A woman of 38 may have an AMH comparable to a woman of 32, or it may be comparable to a woman of 43.
This variability is why treating age alone as a determinant of fertility prognosis is clinically inadequate. AMH must be measured. Antral follicle count (AFC) on ultrasound must be assessed. Only then can the stimulation protocol be calibrated to the actual reserve rather than to a demographic average.
Dr. Anindita Singh's areas of clinical focus include low egg reserve specifically, reflecting her regular management of this patient group and her understanding of which protocol modifications produce the most eggs from a reduced follicular pool.
Rising Chromosomal Abnormality Rate
As eggs age, the cellular machinery responsible for accurately dividing chromosomes during maturation becomes less reliable. The proportion of embryos carrying chromosomal errors (aneuploidy) rises significantly after 35 and steeply after 38. A chromosomally abnormal embryo may fertilise, develop to blastocyst stage, and transfer — but will not implant or will miscarry in early pregnancy.
This is the most common reason repeated IVF cycles fail in women over 38: not because the clinic's technique was wrong, but because the embryos transferred were chromosomally unable to implant. PGT-A (Preimplantation Genetic Testing for Aneuploidy) screens embryos before transfer, identifying those that are chromosomally normal and transferring only those. This is available at Nova IVF Kolkata and directly addresses the most common cause of age-related IVF failure.
Reduced Endometrial Receptivity and Implantation Changes
Women over 35 may also experience subtle changes in endometrial receptivity that standard transfer protocols do not account for. ERA (Endometrial Receptivity Analysis) testing identifies the personalised transfer window, and Dr. Anindita Singh's Nova IVF centre offers this investigation as part of its advanced services for patients with recurrent failure or unexplained implantation difficulty.
Conditions That Complicate Fertility After 35
Several gynaecological conditions become more prevalent or more advanced with age and interact with fertility in ways that require specific management.
Diminished Ovarian Reserve (DOR)
Diminished ovarian reserve is defined as having fewer eggs than expected for a woman's chronological age, combined with a reduced response to ovarian stimulation. It can occur in women in their early thirties, not only after 40.
Management of DOR requires protocol modifications that a standard IVF programme may not apply. These include:
-
Antagonist or short agonist protocols that minimise suppression time before stimulation
-
Adjuvant approaches including testosterone priming, DHEA supplementation, and growth hormone to improve ovarian response
-
Micro-IVF or natural cycle IVF for very low responders where aggressive stimulation yields little
Dr. Anindita Singh's clinical focus on low egg reserve means this patient group is managed with the specific protocol adaptations their biology requires, rather than a default stimulation approach.
PCOS in Women Over 35
PCOS does not resolve at any age. For women over 35 with longstanding PCOS, the hormonal environment surrounding their eggs may include years of androgen excess and metabolic dysregulation. Stimulation in PCOS patients over 35 requires careful balance: the ovaries may be polycystic and prone to OHSS (Ovarian Hyperstimulation Syndrome) with excessive stimulation, while the eggs themselves may be of lower quality than those from younger PCOS patients.
Dr. Anindita Singh has a documented track record in PCOS-related infertility management, with published case studies of successful IVF in PCOS patients who had failed at other centres. Her approach includes a dual trigger protocol using GnRH agonist and hCG to optimise egg maturation a protocol she presented at the ISAR 2017 Annual Conference. This dual trigger approach reduces OHSS risk while improving the proportion of mature eggs retrieved, a specific advantage for older PCOS patients.
Endometriosis
Endometriosis impairs fertility through multiple mechanisms: distorting pelvic anatomy, causing inflammation that reduces egg quality, and creating a hostile endometrial environment for implantation. In women over 35 with moderate to severe endometriosis, the ovarian reserve may be further reduced by endometrioma formation and the inflammatory damage that surrounds them.
Dr. Anindita Singh's areas of focus include endometriosis specifically. Managing an endometriosis patient over 35 requires decisions about whether surgical treatment of endometriomas before IVF is beneficial (the evidence is mixed, and operating on endometriomas can reduce ovarian reserve further) or whether proceeding directly to IVF with the existing reserve is preferable. This is a clinically nuanced decision that requires a specialist who has made it many times across different presentations.
She has also presented a case at BOGSCON 40 on successful IVF in secondary amenorrhea from Asherman's syndrome, demonstrating expertise in the most challenging structural causes of implantation failure a presentation type more common in women with a surgical history, which is more frequently encountered in the over-35 group.
Recurrent Pregnancy Loss Alongside Infertility
Women over 35 experience higher rates of chromosomally abnormal conceptions, which manifest as early miscarriage as well as implantation failure. When early pregnancy is achieved but consistently lost, the investigation must address both the chromosomal quality of embryos and any uterine or immunological factors contributing to pregnancy loss. Dr. Anindita Singh has helped many couples who have failed IVF at other centres, a cohort that often includes women with recurrent miscarriage alongside infertility.
The Treatment Pathway at Nova IVF Kolkata for Women Over 35
Dr. Anindita Singh's approach to female infertility treatment in India for women over 35 follows a structured pathway from investigation through to the most appropriate treatment for each patient's specific presentation.
Complete Baseline Investigation First
Before any treatment is designed, a complete baseline assessment is conducted. This covers:
-
AMH and AFC for ovarian reserve quantification
-
Full hormone panel (FSH, LH, oestradiol, prolactin, TSH, testosterone)
-
Pelvic ultrasound for structural abnormality, endometrioma, and antral follicle count
-
HSG (Hysterosalpingogram) for tubal patency assessment
-
Hysteroscopy where indicated for uterine cavity assessment
-
Blood group, infectious disease screen, and thrombophilia panel where relevant
This foundation prevents misdirected treatment. A woman who appears to have unexplained infertility often has a cause identifiable only through thorough investigation.
Self-Cycle IVF as the First Priority
Dr. Anindita Singh's explicit clinical philosophy prioritises self-cycle IVF using the patient's own eggs over donor egg cycles wherever the ovarian reserve supports this. This preference reflects genuine clinical judgement: many women over 35 who are told their eggs are "too old" by other clinics retain meaningful ovarian function that a personalised protocol can mobilise.
With 2,000 IVF cycles and a specific focus on difficult cases, she has the protocol experience to get the most from a diminished reserve before recommending a transition to donor eggs. For couples who have been told donor eggs are the only option, a consultation with Dr. Anindita Singh through Karetrip provides a genuine second opinion on whether own-egg cycles have been fully explored.
When Donor Eggs Become the Right Decision
When the ovarian reserve has been fully and appropriately assessed and the likelihood of success with own eggs is genuinely low, moving to donor egg IVF is the most evidence-supported decision for women in advanced reproductive age. Nova IVF Kolkata offers a comprehensive donor egg programme under the 2021 ART Regulation Act with health-screened donors typically under 30, at costs significantly lower than donor egg programmes in Western countries.
Advanced Embryology at Nova IVF Kolkata
Nova IVF Kolkata offers the full advanced embryology technology stack relevant to women over 35:
-
ICSI as standard for age-related male factor contribution
-
EmbryoScope time-lapse monitoring for non-invasive embryo development tracking
-
PGT-A for chromosomal screening of embryos before transfer
-
ERA testing for personalised transfer timing
-
MACS sperm selection for concurrent male factor
-
Cryopreservation for frozen embryo transfer cycles
For women who need to understand what each IVF stage involves and how age changes the biology, read: What Are the 5 Stages of IVF and How Does Age Affect Each Stage?
Why International Patients Choose Dr. Anindita Singh and Nova IVF Kolkata
For international patients from Bangladesh, Nepal, the UAE, and the UK, several specific advantages make Nova IVF Kolkata and Dr. Anindita Singh a considered choice.
-
Geographic accessibility: Kolkata is the closest major Indian city to Bangladesh and Nepal, with direct flights and strong transport links. The Nova IVF Kolkata centre on Uttam Kumar Sarani is approximately 38 minutes from Netaji Subhas Chandra Bose International Airport.
-
Clinical depth in difficult cases: Dr. Anindita Singh's specific reputation for handling cases that have failed elsewhere is directly relevant to women over 35 who have already tried treatment without success domestically.
-
Patient-centred availability: Multiple patient testimonials across languages including Bengali, Hindi, and English consistently describe Dr. Anindita Singh's accessibility for questions between appointments, her willingness to explain every step, and her calm presence during difficult moments in the treatment cycle.
-
Cost: A complete IVF cycle with ICSI at Nova IVF Kolkata costs Rs. 1,50,000 to Rs. 2,50,000 (USD 1,800 to USD 3,000). Advanced add-ons including PGT-A and ERA are available at a fraction of Western costs.
How Karetrip Connects International Patients to Dr. Anindita Singh
Karetrip reviews each patient's existing investigation results and IVF cycle history before coordinating a consultation with Dr. Anindita Singh at Nova IVF Kolkata, ensuring the consultation is as productive as possible from the first appointment. From medical visa coordination and accommodation near the Uttam Kumar Sarani centre, through discharge documentation for obstetric follow-up after a successful outcome, Karetrip manages every element of the international patient journey.
Chat with our Medical care assistant, RUA, for quick guidance and support and take the first step toward female infertility treatment in India tailored specifically to the challenges of fertility after 35.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Female infertility requires evaluation by a qualified specialist. Consult a fertility doctor before making any treatment decision.